Molecular Biology Associated with c-Myc
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: closed (30 September 2022) | Viewed by 3935
Special Issue Editor
Interests: c-Myc; c-Myc target gene; regulation of c-Myc; ribosomal proteins; natural compound; apoptosis; metastasis; EMT; cancer stem cell
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Among oncogenic molecules, Myc is elevated or dysregulated in about 70% of human cancers. MYC oncogene family comprising of C-Myc, N-Myc, L-Myc and S-Myc. Among four types of Myc genes, c-Myc is the most oncogenic gene in several cancer cells.
c-Myc oncoprotein is a regulatory factor of cancer cell growth and proliferation. Activation of c-Myc has an important role in cancer development by transcriptionally regulating a number of genes that are involved in cell division, cell survival and ribosome biogenesis. The main focus of this Special Issue will be on the broad spectrum of functions of c-Myc in cancer cells.
We invite all scientists working on c-Myc to participate in this special issue. Original research articles or reviews on all aspects of the molecular and cellular mechanisms modulated by c-Myc in cancer cells are welcome.
We look forward to your contributions.
Prof. Dr. Ji Hoon Jung
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- c-Myc
- MYC
- cancer
- apoptosis
- novel gene
- natural compound
- cancer therapy
- c-Myc target gene
- cancer stem cell
- ribosome biogenesis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
